THE BASIC PRINCIPLES OF ABBV-744 IN ACUTE MYELOID LEUKEMIA (AML)

In Section A, participants will acquire unique doses and schedules of oral ABBV-744 tablet to detect Harmless dosing routine. Extra participants are going to be enrolled for the recognized monotherapy dosign regimen. In Section B, members will obtain oral ruxolitinib and ABBV-744 will probably be given as "insert-on" therapy. In Segment C, contribu